Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
287
Appointments
163
Departures
21
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,399 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | ABM INDUSTRIES INC /DE/ | Rene Jacobsen | Executive Vice President and Chief Operating OfficerCOO | Departed | Feb 1, 2027 | SEC 8-K |
| Oct 28, 2026 | ABM INDUSTRIES INC /DE/ | Rene Jacobsen | Executive AdvisorExecutive Advisor | Role change | Nov 1, 2026 | SEC 8-K |
| Oct 28, 2026 | AIB Data Centers Inc. | Jason K. Burnett | Chief Operations OfficerCOO | Appointed | Oct 26, 2026 | SEC 8-K |
| Oct 28, 2026 | ALIGN TECHNOLOGY INC | Jennifer L. Davis | Chief Executive Officer-elect and directorCEO | Appointed | Nov 2, 2026 | SEC 8-K |
| Oct 28, 2026 | ALIGN TECHNOLOGY INC | Joseph M. Hogan | President and CEOCEO | Departed | Dec 31, 2026 | SEC 8-K |
| Oct 28, 2026 | Arcutis Biotherapeutics, Inc. | Robert Scott | Class II directorClass II director | Appointed | Oct 23, 2026 | SEC 8-K |
| Oct 28, 2026 | Azora Therapeutics, Inc. (DE) | Matthew Davidson, Ph.D. | President and Chief Executive OfficerCEO | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | Azora Therapeutics, Inc. (DE) | Celia Economides | Chief Financial OfficerCFO | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | Azora Therapeutics, Inc. (DE) | Julie Saiki, Ph.D. | Chief Strategy OfficerChief Strategy Officer | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | Azora Therapeutics, Inc. (DE) | Cary J. Claiborne | President and Chief Executive OfficerCEO | Departed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | Azora Therapeutics, Inc. (DE) | Vinay Shah | Chief Financial OfficerCFO | Departed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | Bausch & Lomb Corp | Nathalie Bernier | DirectorDirector | Departed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | Churchill Downs Inc | Michael Tucker | Class II DirectorClass II Director | Appointed | Oct 27, 2026 | SEC 8-K |
| Oct 28, 2026 | COMPASS MINERALS INTERNATIONAL INC | Brett Teuscher | Chief Accounting OfficerChief Accounting Officer | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | ConnectM Technology Solutions, Inc. | Leonardo Riera | Lead Independent DirectorLead Independent Director | Appointed | Oct 21, 2026 | SEC 8-K |
| Oct 28, 2026 | DROPBOX, INC. | Ali Dasdan | Chief Technology OfficerCTO | Departed | Nov 18, 2026 | SEC 8-K |
| Oct 28, 2026 | ENANTA PHARMACEUTICALS INC | Jay R. Luly, Ph.D. | President and Chief Executive OfficerCEO | Departed | Feb 1, 2027 | SEC 8-K |
| Oct 28, 2026 | ENANTA PHARMACEUTICALS INC | Tara L. Kieffer, Ph.D. | Chief Operating OfficerCOO | Appointed | Oct 28, 2026 | SEC 8-K |
| Oct 28, 2026 | ETSY INC | Charles (Lanny) Baker | Chief Financial OfficerCFO | Departed | Mar 1, 2027 | SEC 8-K |
| Oct 28, 2026 | FIRST FINANCIAL BANCORP /OH/ | Timothy A. Massa | directordirector | Appointed | Oct 27, 2026 | SEC 8-K |
- ABM INDUSTRIES INC /DE/Departed
Rene Jacobsen COO
Filed Oct 28, 2026Effective Feb 1, 2027SEC 8-K
- ABM INDUSTRIES INC /DE/Role change
Rene Jacobsen Executive Advisor
Filed Oct 28, 2026Effective Nov 1, 2026SEC 8-K
- AIB Data Centers Inc.Appointed
Jason K. Burnett COO
Filed Oct 28, 2026Effective Oct 26, 2026SEC 8-K
- ALIGN TECHNOLOGY INCAppointed
Jennifer L. Davis CEO
Filed Oct 28, 2026Effective Nov 2, 2026SEC 8-K
- ALIGN TECHNOLOGY INCDeparted
Joseph M. Hogan CEO
Filed Oct 28, 2026Effective Dec 31, 2026SEC 8-K
- Arcutis Biotherapeutics, Inc.Appointed
Robert Scott Class II director
Filed Oct 28, 2026Effective Oct 23, 2026SEC 8-K
- Azora Therapeutics, Inc. (DE)Appointed
Matthew Davidson, Ph.D. CEO
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- Azora Therapeutics, Inc. (DE)Appointed
Celia Economides CFO
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- Azora Therapeutics, Inc. (DE)Appointed
Julie Saiki, Ph.D. Chief Strategy Officer
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- Azora Therapeutics, Inc. (DE)Departed
Cary J. Claiborne CEO
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- Azora Therapeutics, Inc. (DE)Departed
Vinay Shah CFO
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- Bausch & Lomb CorpDeparted
Nathalie Bernier Director
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- Churchill Downs IncAppointed
Michael Tucker Class II Director
Filed Oct 28, 2026Effective Oct 27, 2026SEC 8-K
- COMPASS MINERALS INTERNATIONAL INCAppointed
Brett Teuscher Chief Accounting Officer
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- ConnectM Technology Solutions, Inc.Appointed
Leonardo Riera Lead Independent Director
Filed Oct 28, 2026Effective Oct 21, 2026SEC 8-K
- DROPBOX, INC.Departed
Ali Dasdan CTO
Filed Oct 28, 2026Effective Nov 18, 2026SEC 8-K
- ENANTA PHARMACEUTICALS INCDeparted
Jay R. Luly, Ph.D. CEO
Filed Oct 28, 2026Effective Feb 1, 2027SEC 8-K
- ENANTA PHARMACEUTICALS INCAppointed
Tara L. Kieffer, Ph.D. COO
Filed Oct 28, 2026Effective Oct 28, 2026SEC 8-K
- ETSY INCDeparted
Charles (Lanny) Baker CFO
Filed Oct 28, 2026Effective Mar 1, 2027SEC 8-K
- FIRST FINANCIAL BANCORP /OH/Appointed
Timothy A. Massa director
Filed Oct 28, 2026Effective Oct 27, 2026SEC 8-K